This month, your Academy joined with eight other medical specialties to present the Department of Health and Human Services with recommendations on Medicare Part B and Part D drug coverage. The letter is in response to the President’s 2019 Budget and the Reforming Biopharmaceutical Pricing at Home and Abroad Council of Economic Advisers’ drug plan. The letter outlines concerns regarding proposals which would limit or reduce Part D coverage and shuffle Part B drug coverage under the Medicare Part D program.
View the letter.